Hemolens Diagnostics in the final of the Start-Up-Med competition

The Start-Up-Med competition is a prestigious initiative organized by PTWP Group (Polish Association for Entrepreneurship Support), publisher of, among others, the rynekzdrowia.pl portal and the Rynek Zdrowia magazine. The initiative aims to honor the most innovative and prospective solutions in the medical industry. This year, one of the winners was Hemolens Diagnostics, whose technology attracted a lot of attention from the jury and industry experts. 

Hemolens Diagnostics operates in the medical diagnostics sector and is focused on developing cutting-edge technology to provide a fast and accurate diagnosis of ischemic heart disease. Hemolens Diagnostics’ innovative approach to diagnostics aims to improve the quality of healthcare and accelerate the diagnostics of coronary heart disease. 

The technology developed by Hemolens Diagnostics is based on the use of computational fluid dynamics, allowing for personalized diagnostics by calculating the FFR-CT (fractional flow reserve) index in the coronary arteries. Compared to traditional diagnostic methods, the Hemolens Diagnostics technology can enable faster diagnosis of coronary artery disease, which will impact the effectiveness of treatment. 

As a result of a vote by the Start-Up-Med jury, Hemolens Diagnostics was honored out of 70 submitted companies for its innovative technology and potential in the medical industry. Hemolens Diagnostics’ success is a prestigious award and an opportunity to develop the company and launch the technology on the medical market. 

Recognition at Start-Up-Med is confirmation that it is worthwhile to be involved in the development of innovative diagnostic solutions and to strive to improve the diagnosis of heart disease. Thanks to the PWTR Group’s initiatives, Hemolens Diagnostics has the opportunity to present its proprietary idea to a wide audience at the Health Challenges Congress in Katowice on 9 March 2023.